Radiographic and Histopathologic Observations After Combined EGFR Inhibition and Hypofractionated Stereotactic Radiosurgery in Patients With Recurrent Malignant Gliomas-Reference-Cited by-同舟云学术

Radiographic and Histopathologic Observations After Combined EGFR Inhibition and Hypofractionated Stereotactic Radiosurgery in Patients With Recurrent Malignant Gliomas

Published:2009-04 Issue:5 Volume:73 Page:1352-1357
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Schwer Amanda L.,Kavanagh Brian D.,McCammon Robert,Gaspar Laurie E.,Kleinschmidt-De Masters B.K.,Stuhr Kelly,Chen Changhu

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference14 articles.

1. A phase I dose escalation study of fractionated stereotactic radiosurgery (SRS) in combination with gefitinib in patients with recurrent malignant gliomas;Schwer;Int J Radiat Oncol Biol Phys,2008

2. Radiological response and histological changes in malignant astrocytic tumors after stereotactic radiosurgery;Shinoda;Brain Tumor Pathol,2003

3. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms;Kondziolka;Neurosurgery,1997

4. Stereotactic radiosurgery for recurrent malignant gliomas;Hall;J Clin Oncol,1995

5. Radiation necrosis or glioma recurrence: Is computer assisted stereotactic biopsy useful?;Forsyth;J Neurosurg,1995

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma;International Journal of Radiation Oncology*Biology*Physics;2017-11

2. The role of radiotherapy in the management of progressive glioblastoma;Journal of Neuro-Oncology;2014-04-12

3. Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema;Neuro-Oncology;2014-02-03

4. Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding;Tumor Biology;2013-04-30

5. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer;Journal of Thoracic Oncology;2012-12